Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Nair

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|January 1, 1991
Folate analogues. 34. Synthesis and antitumor activity of non-polyglutamylatable inhibitors of dihydrofolate reductaseA Abraham, J J McGuire, J Galivan, et al.
Journal of Medicinal Chemistry|July 1, 1987
Folate analogues. 30. Synthesis and biological evaluation of N10-propargyl-5,8-dideaza-5,6,7,8-tetrahydrofolic acid and related compoundsM G Nair, R Dhawan, M Ghazala, et al.
Journal of Medicinal Chemistry|September 1, 1981
Folate analogues altered in the C9-N10 bridge region. 18. Synthesis and antitumor evaluation of 11-oxahomoaminopterin and related compoundsM G Nair, T W Bridges, T J Henkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activityS Cao, A Abraham, M G Nair, et al.
The Journal of Biological Chemistry|June 25, 1989
The role of cellular folates in the enhancement of activity of the thymidylate synthase inhibitor 10-propargyl-5,8-dideazafolate against hepatoma cells in vitro by inhibitors of dihydrofolate reductaseJ Galivan, M S Rhee, T B Johnson, et al.
Cancer Research|February 1, 1985
Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductaseY C Cheng, G E Dutschman, M C Starnes, et al.
Advances in Enzyme Regulation|January 1, 1989
The enhancement of the activity of 10-propargyl-5,8-dideazafolate and 5,10-dideazatetrahydrofolate by inhibitors of dihydrofolate reductaseJ Galivan, M S Rhee, T B Johnson, et al.
Cancer Research|January 1, 1989
Inhibition of glycinamide ribonucleotide formyltransferase and other folate enzymes by homofolate polyglutamates in human lymphoma and murine leukemia cell extractsJ Thorndike, Y Gaumont, R L Kisliuk, et al.
Journal of Medicinal Chemistry|September 1, 1986
Folate analogues. 26. Syntheses and antifolate activity of 10-substituted derivatives of 5,8-dideazafolic acid and of the poly-gamma-glutamyl metabolites of N10-propargyl-5,8-dideazafolic acid (PDDF)M G Nair, N T Nanavati, I G Nair, et al.
Journal of Natural Products|March 17, 1999
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherriesH Wang, M G Nair, G M Strasburg, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|January 1, 1991
Folate analogues. 34. Synthesis and antitumor activity of non-polyglutamylatable inhibitors of dihydrofolate reductaseA Abraham, J J McGuire, J Galivan, et al.
Journal of Medicinal Chemistry|July 1, 1987
Folate analogues. 30. Synthesis and biological evaluation of N10-propargyl-5,8-dideaza-5,6,7,8-tetrahydrofolic acid and related compoundsM G Nair, R Dhawan, M Ghazala, et al.
Journal of Medicinal Chemistry|September 1, 1981
Folate analogues altered in the C9-N10 bridge region. 18. Synthesis and antitumor evaluation of 11-oxahomoaminopterin and related compoundsM G Nair, T W Bridges, T J Henkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activityS Cao, A Abraham, M G Nair, et al.
The Journal of Biological Chemistry|June 25, 1989
The role of cellular folates in the enhancement of activity of the thymidylate synthase inhibitor 10-propargyl-5,8-dideazafolate against hepatoma cells in vitro by inhibitors of dihydrofolate reductaseJ Galivan, M S Rhee, T B Johnson, et al.
Cancer Research|February 1, 1985
Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductaseY C Cheng, G E Dutschman, M C Starnes, et al.
Advances in Enzyme Regulation|January 1, 1989
The enhancement of the activity of 10-propargyl-5,8-dideazafolate and 5,10-dideazatetrahydrofolate by inhibitors of dihydrofolate reductaseJ Galivan, M S Rhee, T B Johnson, et al.
Cancer Research|January 1, 1989
Inhibition of glycinamide ribonucleotide formyltransferase and other folate enzymes by homofolate polyglutamates in human lymphoma and murine leukemia cell extractsJ Thorndike, Y Gaumont, R L Kisliuk, et al.
Journal of Medicinal Chemistry|September 1, 1986
Folate analogues. 26. Syntheses and antifolate activity of 10-substituted derivatives of 5,8-dideazafolic acid and of the poly-gamma-glutamyl metabolites of N10-propargyl-5,8-dideazafolic acid (PDDF)M G Nair, N T Nanavati, I G Nair, et al.
Journal of Natural Products|March 17, 1999
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherriesH Wang, M G Nair, G M Strasburg, et al.
Pageof 10